- Filed
- May 27, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 4.84B sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 5.95B sh |
| Shares Outstanding | FY 2025 · Dec 31, 2025 | 6.21B sh |
| Capex | FY 2025 · Dec 31, 2025 | $11.5K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$306.4K |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$378.41K |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $11.62K |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $10.46K |
| Stockholders Equity restated | FY 2025 · Dec 31, 2025 | $242.77M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | $241.08M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $5.05M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $5.03M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $5.06M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $5.18M |
| Current Assets | FY 2025 · Dec 31, 2025 | $145.98K |
| Current Assets | FY 2025 · Dec 31, 2024 | $16.95K |
| Total Assets restated | FY 2025 · Dec 31, 2025 | $247.83M |
| Total Assets restated | FY 2025 · Dec 31, 2024 | $246.26M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.00 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | $0.00 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.00 |
| Eps Basic | FY 2025 · Dec 31, 2024 | $0.00 |
| Rd Expense | FY 2025 · Dec 31, 2025 | $8.06K |
| Rd Expense | FY 2025 · Dec 31, 2024 | $10.24K |
| Net Income | FY 2025 · Dec 31, 2025 | −$291.52K |
| Net Income | FY 2025 · Dec 31, 2024 | $396.76K |
| Operating Income | FY 2025 · Dec 31, 2025 | −$434.82K |
| Operating Income | FY 2025 · Dec 31, 2024 | −$366.62K |
| Gross Profit | FY 2025 · Dec 31, 2024 | $5K |
| Revenue | FY 2025 · Dec 31, 2024 | $5K |